Home » Media

Media

International Program Spotlights the BRICs at the 2013 BIO International Convention
With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities...
Farmers Increasingly Favor Biotech Crops
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420...

Press Releases

BIO Industry Analysis Investor Survey: FDA Approvals Expected to Increase and Majority of Investors Believe Now is a Good Time to Invest in Biotech
Feb 15 2012
WASHINGTON, DC (February 15, 2012) – The 14th annual BIO CEO & Investor Conference wrapped up in New York City yesterday amidst renewed optimism...
Administration‘s 2013 Budget Could Discourage Development of Cures and Breakthrough Medicines, Limit Patient Choice And Forestall Job Growth
Feb 14 2012
  (February 14, 2011) –Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement in response to...
BIO’s 9th Annual World Congress on Industrial Biotechnology and Bioprocessing in Orlando to Feature Presentations on Advanced Biofuels and Renewable Chemicals
Feb 9 2012
WASHINGTON, D.C. (Feb. 9, 2012) – Biofuel and renewable chemical company executives, scientists and government officials from around the globe will...
Release of FDA Guidance for Biosimilars Pathway Marks Important Step Forward, Says BIO
Feb 9 2012
Patient Safety Must Remain Top Priority Washington, D.C. (February 9, 2012) — Biotechnology Industry Organization (BIO) President and CEO Jim...
More Farmers Favor Biotech Crops
Feb 7 2012
Adoption of Agricultural Biotechnology Increased Eight Percent Over Past Year WASHINGTON, D.C. (February 07, 2012) – Because of their tremendous...
BIO Testifies on Importance of Prompt Enactment of PDUFA V Recommendations
Feb 1 2012
Washington, D.C. (February 1, 2012) – Richard Pops, Chairman and CEO of Alkermes plc, testified today on behalf of the Biotechnology Industry...
14th Annual BIO CEO & Investor Conference to Highlight 2012 Investment Outlook, New Business Models and Key Therapeutic Topics
Jan 31 2012
WASHINGTON, D.C. (January 31, 2012) –The Biotechnology Industry Organization (BIO) announces plenary sessions, Business Roundtables and Therapeutic...
BIO Congratulates ZeaChem, Applauds USDA Loan Guarantee Announcement
Jan 26 2012
Biorefineries continue to make progress toward commercial-scale production of cellulosic and advanced biofuels, with vital assistance from the USDA loan...
Biotechnology Can Provide Foundation for A U.S. Economy “Built To Last”
Jan 25 2012
BIO Calls On the Administration and Congress to Embrace Proposals to Unleash the Promise of Biotechnology WASHINGTON, D.C. (Wednesday, January 25, 2012) -...
2012 BIO International Convention to Highlight Insights from Senior Biotech Executives on Latest Trends, Emerging Policy, and Business Development Issues
Jan 25 2012
WASHINGTON, DC – (January 25, 2012) - The 2012 BIO International Convention will feature a program packed with more than 125 sessions and speakers...


Biotechnology News

Idera Announces Presentation at AAD Annual Meeting Demonstrating Toll-like Receptor Antagonists Normalize Expression of Inflammatory Genes in Psoriasis Model
March 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera presented new data showing that its selective Toll-like receptor antagonists normalized the gene expression of important cytokines...

Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of PASI-75 in the First Phase III Study (ESTEEM 1) in Patients with Psoriasis
March 2, 2013

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from ESTEEM 1, the Company...

KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101 in the Reduction of Unwanted Submental Fat (SMF) or “Double Chin”
March 2, 2013

MIAMI BEACH, Fla.--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multi-center, open-label...

‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says the Committee on Fair Drug Pricing (a.k.a. FAIR)
March 1, 2013

SAN FRANCISCO--(BUSINESS WIRE)--‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says Committee on Fair Drug Pricing (a.k.a. FAIR)-Coalition of...

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4
March 1, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Cowen and Company 33rd...